The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 3.7% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 1%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (8 analysts) rates it none, with a mean price target of $754.
Volution Group plc
FAN.L · LSE · GBp · Market cap $127.5B · 2,200 employees
Volution Group plc, together with its subsidiaries, engages in the manufacture and supply of ventilation products to residential and commercial constructions in the United Kingdom, Continental Europe, and Australasia.
Not yet scoredPrice as of 13 Nov 2026Daily close, not a live quote
Screened 2026-11-13 · the tape above runs as of 08:09 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price641.00 GBp at the 13 Nov 2026 close
- Our value readOvervalued vs our fair value, as of 13 Nov 2026
- Our regime readAccumulation, as of 15 Nov 2026
- Ethical screenNot yet scored
- Last reviewed13 Nov 2026 (3 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: 376.16 GBp to 432.58 GBp, base estimate 376.16 GBp (screen dated 2026-11-13).
- Trend Accumulation
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical screen not yet scored
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its accumulation label.
Volution Group plc holds its Accumulation at $641.00. Elevated stress, defensive posture warranted, held for 53 days.
| Phase | Accumulation |
| Quantitative state | Elevated stress, defensive posture warranted, held for 53 days |
| Price at the screen | $641.00 |
| Valuation | 2,476.92 trailing · 1,642.10 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 1.17 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 19.98% | Below 33% | Interest-bearing debt is just 20.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 14.74% | Below 49% | Money owed to the company is 14.7% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.04% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Volution clears the business-activity screen and the figures we can measure look clean, but its income-purity figure is still pending, so the verdict is not final yet.
Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 13 Nov 2026: it trades above our 376.16 GBp fair value estimate, 21.70% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in GBp, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. The price runs 70.4% above the base estimate.
Third-party analyst targets. The average target sits +17% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
ProjectionsWhere our models see it going: fair-value estimate 376.16 GBp, with a range of 376.16 GBp to 432.58 GBp, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it gives us pause
At 1,642.1x forward earnings, the price already runs ahead of the business. It trades 70% above our 376.16 GBp fair value, so you would be buying at a premium, not a discount.
| Forward P/E | 1,642.1xexpensive even after accounting for its growth |
| Trailing P/E | 2,476.9xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 0.26 |
| EPS, forward | 0.39 |
| Revenue growth | +21.7%strong top-line growth |
| Profit margin | 11.2%thin but positive margins |
| Return on equity | 19.1%a solid return on shareholder capital |
| FCF yield | 2.99% |
| Dividend yield | 1.88% |
| Debt to equity | 1.01a meaningful debt load worth watching |
| Current ratio | 2.74comfortably covers its short-term bills |
| Beta | 1.17moves a little more than the market |
| 52-week range | 547.00 - 730.00 |
| Market cap | $127.5B |
| Employees | 2,200 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: its business and earnings are exposed to United Kingdom and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeFAN.L trades on LSE (the company is based in United Kingdom). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 4.7% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are down 1%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (8 analysts) rates it none, with a mean price target of $754.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 1%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (8 analysts) rates it none, with a mean price target of $754.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 7.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 1%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (8 analysts) rates it none, with a mean price target of $754. Since the last review it its composite score eased.
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 1%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (8 analysts) rates it none, with a mean price target of $754.
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 1%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (8 analysts) rates it none, with a mean price target of $754.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 1%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (8 analysts) rates it none, with a mean price target of $754.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $620.00 | -3.2% | · | $968 | -3.2% |
| 2 months | $630.00 | -4.8% | · | $952 | -4.8% |
| 3 months | $623.96 | -3.8% | $4.00 | $968 | -3.2% |
| 6 months | $627.96 | -4.5% | $4.00 | $962 | -3.8% |
| 1 year | $607.88 | -1.3% | $11.40 | $1,006 | +0.6% |
| 2 years | $443.84 | +35.2% | $21.00 | $1,399 | +39.9% |
| 3 years | $424.76 | +41.3% | $29.30 | $1,482 | +48.2% |
| 5 years | $393.64 | +52.4% | $43.50 | $1,635 | +63.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever FAN.L does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.